The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats
- PMID: 18093985
- DOI: 10.1093/cvr/cvm112
The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats
Abstract
Aims: The present study examined the hypothesis that prostaglandin E2 (PGE2) through activation of prostaglandin E (EP) receptor contributes to endothelium-dependent contractions.
Methods and results: Western blotting revealed that the protein expression of EP1 receptor was significantly down-regulated in the aorta of the spontaneously hypertensive rat (SHR), but there was no significant difference in the expression of EP2, EP4, and total EP3 receptors between preparations of Wistar Kyoto rats (WKY) and SHR. Isometric tension studies showed that low concentrations of PGE2 caused endothelium-dependent relaxations in WKY but not in aortas of the SHR. High concentrations of PGE2 evoked contractions predominately through the activation of thromboxane-prostanoid (TP) receptors in the WKY, but involves the dual activation EP and TP receptors in the SHR. SQ29,548, BAYu3405 and Terutroban (TP receptor antagonists), and AH6809 (non-selective EP receptor antagonist) abolished, while SC19220 (preferential EP1 receptor antagonist) did not inhibit endothelium-dependent contractions. Both SC19220 and AH6809 significantly inhibited contractions to U46619 (TP receptor agonist).
Conclusion: The present study demonstrates that the contraction caused by PGE2 in the SHR aorta is dependent on the activation of EP1 and TP receptors, but that endothelium-dependent contractions do not require the former. Thus, PGE2 is unlikely to be an endothelium-derived contracting factor in this artery. The ability of AH6809 to inhibit endothelium-dependent contractions can be attributed to its partial antagonism at TP receptors. Nevertheless, the impairment of PGE2-mediated relaxation may contribute to endothelial dysfunction in the aorta of the SHR.
Similar articles
-
Vasoconstrictor prostanoids.Pflugers Arch. 2010 May;459(6):941-50. doi: 10.1007/s00424-010-0812-6. Epub 2010 Mar 24. Pflugers Arch. 2010. PMID: 20333529 Review.
-
Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors.Br J Pharmacol. 2009 Feb;156(4):563-74. doi: 10.1111/j.1476-5381.2008.00060.x. Epub 2009 Jan 19. Br J Pharmacol. 2009. PMID: 19154435 Free PMC article. Review.
-
Hypertension and the absence of EDHF-mediated responses favour endothelium-dependent contractions in renal arteries of the rat.Br J Pharmacol. 2008 Sep;155(2):217-26. doi: 10.1038/bjp.2008.256. Epub 2008 Jun 23. Br J Pharmacol. 2008. PMID: 18574459 Free PMC article.
-
Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin.Br J Pharmacol. 2005 Nov;146(6):834-45. doi: 10.1038/sj.bjp.0706390. Br J Pharmacol. 2005. PMID: 16158068 Free PMC article.
-
Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.Br J Pharmacol. 2001 Dec;134(8):1671-8. doi: 10.1038/sj.bjp.0704423. Br J Pharmacol. 2001. PMID: 11739243 Free PMC article.
Cited by
-
Hypertension in chronic kidney disease: What lies behind the scene.Front Pharmacol. 2022 Oct 11;13:949260. doi: 10.3389/fphar.2022.949260. eCollection 2022. Front Pharmacol. 2022. PMID: 36304157 Free PMC article. Review.
-
Sexual dimorphism in prostacyclin-mimetic responses within rat mesenteric arteries: A novel role for KV 7.1 in shaping IP receptor-mediated relaxation.Br J Pharmacol. 2022 Apr;179(7):1338-1352. doi: 10.1111/bph.15722. Epub 2022 Jan 21. Br J Pharmacol. 2022. PMID: 34766649 Free PMC article.
-
Cyclo-Oxygenase (COX) Inhibitors and Cardiovascular Risk: Are Non-Steroidal Anti-Inflammatory Drugs Really Anti-Inflammatory?Int J Mol Sci. 2019 Aug 30;20(17):4262. doi: 10.3390/ijms20174262. Int J Mol Sci. 2019. PMID: 31480335 Free PMC article. Review.
-
Relaxin reduces endothelium-derived vasoconstriction in hypertension: Revealing new therapeutic insights.Br J Pharmacol. 2020 Jan;177(1):217-233. doi: 10.1111/bph.14858. Epub 2019 Oct 31. Br J Pharmacol. 2020. PMID: 31479151 Free PMC article.
-
Increased role of E prostanoid receptor-3 in prostacyclin-evoked contractile activity of spontaneously hypertensive rat mesenteric resistance arteries.Sci Rep. 2017 Aug 21;7(1):8927. doi: 10.1038/s41598-017-09288-w. Sci Rep. 2017. PMID: 28827689 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical